Clinical Trial Update: Reversal of an Unfavorable Effect of Hydrochlorothiazide Compared to Angiotensin Converting Enzyme Inhibitor on Serum Uric Acid and Oxypurines Levels by Estrogen-progestin Therapy in Hypertensive Postmenopausal Women. [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether estrogen-progestin therapy reverses an unfavorable effect of hydrochlorothiazide on serum uric acid and oxypurine levels in hyp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Hyperuricemia
• Menopause

Drugs mentioned

• Angiotensin-converting enzyme inhibitor (angiotensin-converting enzyme inhibitor)
• Estrogen/progestin therapy (Conjugated estrogens with medroxyprogesterone acetate)
• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)

Snippet

Sponsor: Anna Posadzy-Małaczyńska | Conditions: Hypertension, Hyperuricemia | Phase 4 | Status: COMPLETED